-
1
-
-
33947186284
-
Metabolic diversity of the intestinal microbiota: Implications for health and disease
-
Blaut M, Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr. 2007; 137(3)(suppl 2):751S-755S.
-
(2007)
J Nutr.
, vol.137
, Issue.3 SUPPL. 2
-
-
Blaut, M.1
Clavel, T.2
-
3
-
-
71549146864
-
Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces
-
Mulder IE, Schmidt B, Stokes CR, et al. Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces. BMC Biol. 2009; 7:79.
-
(2009)
BMC Biol
, vol.7
, pp. 79
-
-
Mulder, I.E.1
Schmidt, B.2
Stokes, C.R.3
-
4
-
-
0010369584
-
-
Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, ONT, Canada: Food and Agriculture Organization of the United Nations, World Health Organization;
-
Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, ONT, Canada: Food and Agriculture Organization of the United Nations, World Health Organization; 2002.
-
(2002)
Guidelines for the Evaluation of Probiotics in Food
-
-
-
5
-
-
84893687483
-
Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: Meta-analysis of randomized controlled trials
-
Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014; 20(1):21-35.
-
(2014)
Inflamm Bowel Dis.
, vol.20
, Issue.1
, pp. 21-35
-
-
Shen, J.1
Zuo, Z.X.2
Mao, A.P.3
-
6
-
-
77749318556
-
The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review
-
Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010; 59(3):325-332.
-
(2010)
Gut.
, vol.59
, Issue.3
, pp. 325-332
-
-
Moayyedi, P.1
Ford, A.C.2
Talley, N.J.3
-
7
-
-
69049095260
-
Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: A meta-analysis
-
Alfaleh K, Anabrees J, Bassler D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology. 2010; 97(2): 93-99.
-
(2010)
Neonatology
, vol.97
, Issue.2
, pp. 93-99
-
-
Alfaleh, K.1
Anabrees, J.2
Bassler, D.3
-
8
-
-
33947169259
-
Probiotics and prebiotics: Effects on diarrhea
-
de Vrese M, Marteau PR. Probiotics and prebiotics: effects on diarrhea. J Nutr. 2007; 137(3)(suppl 2):803S-8011S.
-
(2007)
J Nutr.
, vol.137
, Issue.3 SUPPL. 2
-
-
De Vrese, M.1
Marteau, P.R.2
-
10
-
-
84883184463
-
Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility
-
Scaldaferri F, Gerardi V, Lopetuso LR, et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int. 2013; 2013:435268.
-
(2013)
Biomed Res Int.
, vol.2013
, pp. 435268
-
-
Scaldaferri, F.1
Gerardi, V.2
Lopetuso, L.R.3
-
11
-
-
78149272756
-
Prebiotic effects: Metabolic and health benefits
-
Roberfroid M, Gibson GR, Hoyles L, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr. 2010; 104(suppl 2):S1-S63.
-
(2010)
Br J Nutr.
, vol.104
, Issue.SUPPL. 2
-
-
Roberfroid, M.1
Gibson, G.R.2
Hoyles, L.3
-
12
-
-
59149093199
-
Clinical trial: The effects of a transgalactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome
-
Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson G R. Clinical trial: the effects of a transgalactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009; 29(5):508-518.
-
(2009)
Aliment Pharmacol Ther.
, vol.29
, Issue.5
, pp. 508-518
-
-
Silk, D.B.1
Davis, A.2
Vulevic, J.3
Tzortzis, G.4
Gibson, G.R.5
-
13
-
-
84861337187
-
Inulin and fructo-oligosaccharides for the prevention of antibiotic-associated diarrhea in children. Report by the ESPGHAN working group on probiotics and prebiotics
-
ESPGHAN Working Group on Probiotics and Prebiotics
-
ESPGHAN Working Group on Probiotics and Prebiotics, Szajewska H, Weizman Z, et al. Inulin and fructo-oligosaccharides for the prevention of antibiotic-associated diarrhea in children. Report by the ESPGHAN working group on probiotics and prebiotics. J Pediatr Gastroenterol Nutr. 2012; 54(6):828-829.
-
(2012)
J Pediatr Gastroenterol Nutr.
, vol.54
, Issue.6
, pp. 828-829
-
-
Szajewska, H.1
Weizman, Z.2
-
14
-
-
84887619413
-
Prebiotic supplementation in preterm neonates: Updated systematic review and meta-analysis of randomised controlled trials
-
Srinivasjois R, Rao S, Patole S. Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials. Clin Nutr. 2013; 32(6):958-965.
-
(2013)
Clin Nutr.
, vol.32
, Issue.6
, pp. 958-965
-
-
Srinivasjois, R.1
Rao, S.2
Patole, S.3
-
15
-
-
84887390865
-
Lactobacilli and bifidobacteria in the prevention of antibioticassociated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): A randomised, double-blind, placebo-controlled, multicentre trial
-
Allen SJ, Wareham K, Wang D, et al. Lactobacilli and bifidobacteria in the prevention of antibioticassociated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013; 382(9900):1249-1257.
-
(2013)
Lancet
, vol.382
, Issue.9900
, pp. 1249-1257
-
-
Allen, S.J.1
Wareham, K.2
Wang, D.3
-
17
-
-
77957583411
-
Probiotics as therapy in gastroenterology: A study of physician opinions and recommendations
-
Williams MD, Ha CY, Ciorba MA. Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations. J Clin Gastroenterol. 2010; 44(9):631-636.
-
(2010)
J Clin Gastroenterol
, vol.44
, Issue.9
, pp. 631-636
-
-
Williams, M.D.1
Ha, C.Y.2
Ciorba, M.A.3
|